Bisphenol A (BPA) leading to obesity and cardiovascular complications: a compilation of current in vivo study
BPA is one of the most common endocrine disruptors that is widely being manufactured daily nationwide. Although scientific evidence supports claims of negative effects of BPA on humans, there is also evidence suggesting that a low level of BPA is safe. However, numerous in vivo trials contraindicate...
Saved in:
| Main Authors: | Naomi, Ruth, Yazid, Muhammad Dain, Bahari, Hasnah, Yong, Yoke Keong, Rajandram, Retnagowri, Embong, Hashim, Soo, Huat Teoh, Halim, Shariff, Othman, Fezah |
|---|---|
| Format: | Article |
| Published: |
MDPI
2022
|
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Managing cardiovascular complications in diabetes /
Published: (2014) -
Adverse effects of bisphenol a on the liver and its underlying mechanisms: evidence from in vivo and in vitro studies
by: Abdulhameed, Al-Salihi Ahmed Rashid, et al.
Published: (2022) -
Complications of cardiovascular procedures : risk factors, management, and bailout techniques /
Published: (2011) -
The role of oxidative stress and inflammation in obesity and its impact on cognitive impairments —a narrative review
by: Naomi, Ruth, et al.
Published: (2023) -
Effects of BPA-organic fertilizer on performance of Eksotika papaya
by: Zabedah M.
Published: (2015)
